pink opioid pills Clopidogrel noninferior for patients older than 65 years after acute coronary syndrome hospitalization. (HealthDay News) — For patients aged older than 65 years with an acute ...

Weston, ON - Major US pharmacies have started selling Apotex Corp's generic clopidogrel, despite protestations by the manufacturer and marketer of brand-name Plavix (Bristol-Myers Squibb ...

Patients with ACS who were prescribed generic clopidogrel had similar rates of death and recurrent hospitalization compared with those prescribed the brand-name version, according to a study published ...

Feb. 21, 2006 -- The US Food and Drug Administration (FDA) has approved first-time generic formulations of cyclobenzaprine HCl 5-mg tablets for adjunctive use in the short-term treatment of muscle ...

Generic clopidogrel is just as good as name brand Plavix for acute coronary syndrome patients taking it after discharge, an observational study suggested. An angry red rash being called “COVID arm” is ...

DALLAS, March 13, 2018 - Generic anti-platelet drugs seem to work as well as a brand name drug for heart patients, according to new research in Circulation: Cardiovascular Quality and Outcomes, an ...

Pittsburgh-based Mylan Pharmaceuticals will be the first company to produce a generic version of a popular blood thinner. According to Philly.com, the FDA has approved generic form Plavix. Companies ...

A generic version of the standard antiplatelet agent clopidogrel used in Italy may do a worse job of suppressing platelet reactivity than the brand-name form of the drug, according to lab data from an ...

The commonly prescribed blood thinner clopidogrel should replace aspirin as a routine pill for preventing heart attacks and strokes in people who already have at least some degree of heart disease, ...

The Food and Drug Administration on Tuesday said a Canadian company could sell a generic version of the anticoagulant Plavix, the biggest-selling drug for , the developer of Plavix and the marketing ...

LONDON (Reuters) - Sanofi-Aventis and Bristol-Myers Squibb , which are just recovering from defeating generic competition to their top-selling Plavix drug in the United States, now face a similar ...

The researchers found that the primary outcome was experienced by 17.6% of patients prescribed Plavix and 17.9% prescribed clopidogrel at 1 year (hazard ratio, 1.02; 95% confidence interval, 0.96 to 1 ...